LEARN ABOUT THIS STUDY – WITH STUDY CENTERS IN USA AND OUTSIDE OF USA HERE: https://cypress-study.com/ Theravance Biopharma is researching the investigational drug (ampreloxetine) because they believe it may reduce nOH symptoms that interfere with daily activity in MSA patients based on prior clinical trial results. They are running the Phase 3 CYPRESS trial to […]
Copyright: ©2023-2024; Defeat MSA Alliance, All rights reserved. The brand names “Defeat MSA” and “Defeat Multiple System Atrophy” are trademarked and wholly owned by Defeat MSA Alliance. No part of this website may be copied without the express permission of Defeat MSA Alliance. For information, contact the trademark and copyright holder: copyright@defeatmsa.org
